| | | | | | Applications are now open for the 2026 Mission BioCapital Platinum Program
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | Siren Biotechnology Announces FDA Clearance of Investigator-Initiated IND to Advance Phase 1 Study in Recurrent High-Grade Glioma
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | Latent Labs Launches Latent-Y, an AI Agent That Autonomously Designs Antibodies From a Text Prompt, Compressing Weeks of Expert Work Into Hours
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | General Proximity Announces $12M, 2x Over-Subscribed, Pre-Series A Round
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | Therna Announces Collaboration with Charles River to Advance Single-Patient Personalized RNA Therapeutics
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | Genentech and DeepSeq Peer-Reviewed Papers: Maturing AI Hits into Leads
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | Qymune Announces Research Collaboration with Daiichi Sankyo to Advance Next-Generation T Cell Engager Technology
READ MORE ► |
|
|
|
|
|
|
|
|
|
|
|
| | | | Agilent Presents: Mass Spectrometry 101
April 8 @ noon - 1pm
1030 Brittan Ave, San Carlos
Accelerate your Science with the MBC BioLabs Advanced Mass Spectrometry Center. Led by Dr. Yanan Yang in partnership with Agilent, the center is built to support our community with powerful, accessible, and expert-driven mass spectrometry analysis.
Join us for an exploratory discussion on Mass Spectrometry, covering fundamentals like including nominal vs. accurate mass measurements, an overview of different instrument types, and the advantages of high-resolution mass accuracy and isotopic fidelity for compound identification. Attendees will also learn about the mass spectrometry capabilities and services available on-site at MBC BioLabs.
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
| Equity Planning & Cap Table Considerations
April 9 @ noon - 2pm
135 Mississippi St, San Francisco
REGISTER ►
April 9 @ 4pm - 6pm
1030 Brittan Ave, San Carlos
REGISTER ►
Our friends with J.P. Morgan's Private Bank and Workforce Solutions team will be on-site to discuss how founders can navigate equity and cap table decisions. Whether you're early-stage and just getting started or approaching a liquidity event, this is a candid, practical conversation designed to help you make more informed decisions about your equity. |
|
|
|
|
|
|
|
|
|
|
|
| Founders & Finance: A J.P. Morgan Investment Banking Market Briefing
April 16 @ noon - 1pm
1030 Brittan Ave, San Carlos
We're excited to welcome David Choi, Executive Director of Healthcare Investment Banking at J.P. Morgan, to MBC BioLabs for an exclusive session designed for our community of founders, entrepreneurs, and scientists. David brings deep expertise in biopharma M&A and capital markets and will join Sean Storms, Executive Director of Life Science Commercial Banking at J.P. Morgan, for a fireside chat on the current macro and life sciences financing landscape — and what it means for founders raising capital or planning exits in 2026.
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
| | | | MBC BioLabs Longevity Innovation Forum
April 2 @ 3pm - 7:30pm
1030 Brittan Ave, San Carlos
Join us for our fifth Innovation Forum, where we'll highlight pioneering startups reimagining how we prevent and treat age-related disease. We’re bringing together the community of founders, funders, and partners driving the future of healthspan.
Space is limited and priority registration will be granted to founders and funders building in longevity.
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
| Sierra Nights: AI for Biotech - Show & Tell
April 8 @ 5pm - 8pm
1030 Brittan Ave, San Carlos
Sierra Nights is an event series focused on the parts of biotech that don’t show up on slides: the gaps people are dealing with, the tools they’re using, and the signals worth paying attention to. No pitching. No marketing. Just real conversations. It’s a space to share experiences about what’s working, what’s failing, and what still feels like hype.
Join us for the first Sierra Night: AI in Biotech – Show & Tell. Compare notes on AI tools for biotech, minor victories, noble failures, and what may yet save us all a few months of suffering.
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
| Founders at Work: Myka Labs
April 15 @ noon - 1pm
135 Mississippi St, San Francisco
From Fetal Surgery to Transformer-Based AI: The Next Frontier of Minimally Invasive Intervention
Minimally invasive surgery remains limited by inadequate intraoperative imaging, contributing to high complication rates. Myka Labs’ Glint system addresses this with real-time, spatial visualization and analytics powered by transformer-based deep learning models and multimodality, as well as smart catheter technology. In this FAW talk, fetal surgery pioneer, Dr. Mike Harrison, and CEO of Myka Labs, Dan Laser, will explore the AI, biology, and clinical history shaping the future of incision-free surgery.
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
| Unblock and Inspire: Peer support conversations for women leaders
April 22 @ 5pm - 7pm
135 Mississippi St, San Francisco
The Greenhouse is a community for women leading planet-positive solutions.
Join them at MBC BioLabs for a warm, intimate gathering where women entrepreneurs and leaders come together in small peer groups to work through real challenges, offer each other perspective, and leave feeling genuinely energized. No keynotes. No performance. Just honest conversation with brilliant women who get it.
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
| Bits in Bio Presents: Engineering a Climate-Safe Future with Biology
April 23 @ 6pm - 9pm
135 Mississippi St, San Francisco
Bits in Bio presents Biology as Climate Infrastructure - Lightning Talks. Join us to hear 5-minute lightning talks from companies working across agriculture and soil biology, alternative proteins, biomanufacturing and scale-up, plastic degradation with biology, and more!
REGISTER ► |
|
|
|
|
|
|
|
|
|
|
|
| | | | | Powerhouse Biology is led by co-founders, CEO Mariëlle van Kooten, and CSO, Rachel Jacobson. Their team is based at 1030 Brittan Avenue, San Carlos.
Powerhouse Biology is an end-to-end techbio platform company engineering mitochondrial therapeutics to extend healthy human lifespan. The company systematically explores mitochondrial biology across kingdoms to discover nature-refined, life-promoting mechanisms that humans do not (yet) utilize. Using AI-guided design, they engineer these functions into human therapeutics. Their platform integrates high-dimensional, multimodal data into a machine learning framework that produces mechanistically defined and validated candidates, targeting resilience and durability centered on the mitochondria and extending throughout the cell. |
|
| | | | |
|
|
|
|
|
